These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 27478005

  • 1. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease.
    Jongsma H, Bekken JA, de Vries JP, Verhagen HJ, Fioole B.
    J Vasc Surg; 2016 Nov; 64(5):1503-1514. PubMed ID: 27478005
    [Abstract] [Full Text] [Related]

  • 2. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
    Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D.
    J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
    [Abstract] [Full Text] [Related]

  • 3. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
    Kayssi A, Al-Jundi W, Papia G, Kucey DS, Forbes T, Rajan DK, Neville R, Dueck AD.
    Cochrane Database Syst Rev; 2019 Jan 26; 1(1):CD012510. PubMed ID: 30684445
    [Abstract] [Full Text] [Related]

  • 4. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G, Liu J, Jia S, Zhang J, Zhuang B, Jia X, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W, AcoArt I Trial Investigators.
    Vascular; 2021 Jun 26; 29(3):340-349. PubMed ID: 32903168
    [Abstract] [Full Text] [Related]

  • 5. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K.
    JACC Cardiovasc Interv; 2014 Jan 26; 7(1):10-9. PubMed ID: 24456716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep 26; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H, van Mierlo-van den Broek P, Imani F, van den Heuvel D, de Vries JPM, Fioole B.
    J Vasc Surg; 2017 Oct 26; 66(4):1293-1298. PubMed ID: 28826727
    [Abstract] [Full Text] [Related]

  • 9. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    JACC Cardiovasc Interv; 2013 Dec 26; 6(12):1295-302. PubMed ID: 24239203
    [Abstract] [Full Text] [Related]

  • 10. Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial.
    Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W.
    JACC Cardiovasc Interv; 2016 Sep 26; 9(18):1941-9. PubMed ID: 27659572
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
    Zeller T, Brechtel K, Meyer DR, Noory E, Beschorner U, Albrecht T.
    J Endovasc Ther; 2020 Oct 26; 27(5):683-690. PubMed ID: 32666871
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
    Teichgräber U, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Thieme M, Blessing E, Treitl M, Lichtenberg M, von Flotow P, Vogel B, Werk M, Riambau V, Wienke A, Lehmann T, Sixt S.
    Trials; 2016 Oct 28; 17(1):528. PubMed ID: 27793175
    [Abstract] [Full Text] [Related]

  • 14. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun 28; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 15. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial.
    Tepe G, Schnorr B, Albrecht T, Brechtel K, Claussen CD, Scheller B, Speck U, Zeller T.
    JACC Cardiovasc Interv; 2015 Jan 28; 8(1 Pt A):102-8. PubMed ID: 25616822
    [Abstract] [Full Text] [Related]

  • 16. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials.
    Anantha-Narayanan M, Shah SM, Jelani QU, Garcia S, Ionescu C, Regan C, Mena-Hurtado C.
    Catheter Cardiovasc Interv; 2019 Jul 01; 94(1):139-148. PubMed ID: 30838719
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.
    Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    J Endovasc Ther; 2014 Feb 01; 21(1):1-8. PubMed ID: 24502477
    [Abstract] [Full Text] [Related]

  • 18. Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis.
    Feng H, Chen X, Guo X, Zhang Z, Zhang Z, Liu B, Lian L.
    BMC Cardiovasc Disord; 2020 Aug 31; 20(1):395. PubMed ID: 32867681
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    J Endovasc Ther; 2016 Feb 31; 23(1):52-7. PubMed ID: 26511896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.